Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Liu, Lingling ^a   Wu, Jing ^a   Ong, Su Sien ^a   Chen, Taosheng ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; FASCAPLYSIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN PHOSPHORYLATION; RHABDOMYOSARCOMA; SARCOMA CELL; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 4; CYTOPLASM; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RHABDOMYOSARCOMA, ALVEOLAR; TRANSCRIPTION, GENETIC;

EID: 84874560997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058193     Document Type: Article

References (23)

1. Amstutz R, Wachtel M, Troxler H, Kleinert P, Ebauer M, et al. (2008) Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities. Cancer Res 68: 3767-3776.
2. Linardic CM, (2008) PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett 270: 10-18.
3. Xia SJ, Pressey JG, Barr FG, (2002) Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 1: 97-104.
4. Linardic CM, Naini S, Herndon JE 2nd, Kesserwan C, Qualman SJ, et al (2007) The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence. Cancer Res 67: 6691-6699.
5. Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, et al. (2004) Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 18: 2614-2626.
6. Keller C, Capecchi MR, (2005) New genetic tactics to model alveolar rhabdomyosarcoma in the mouse. Cancer Res 65: 7530-7532.
7. Liu L, Wang YD, Wu J, Cui J, Chen T, (2012) Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells. BMC Cancer 12: 154.
8. Zeng FY, Dong H, Cui J, Liu L, Chen T, (2010) Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells. Biochem Biophys Res Commun 391: 1049-1055.
9. Zeng FY, Cui J, Liu L, Chen T, (2009) PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis. Cancer Lett 284: 157-164.
10. van den Heuvel S, Harlow E, (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
11. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, et al. (1998) Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci U S A 95: 1392-1397.
12. Lin W, Wu J, Dong H, Bouck D, Zeng FY, et al. (2008) Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells. J Biol Chem 283: 30650-30657.
13. Liu L, Chen T (2012) PAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells. J Can Res Updates 1: 49-56, 2012.
14. Bouck DC, Shu P, Cui J, Shelat A, Chen T, (2011) A high-content screen identifies inhibitors of nuclear export of forkhead transcription factors. J Biomol Screen 16: 394-404.
15. Aubry C, Wilson AJ, Emmerson D, Murphy E, Chan YY, et al. (2009) Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1. Bioorg Med Chem 17: 6073-6084.
16. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ, (2006) CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314: 294-297.
17. Liu P, Kao TP, Huang H, (2008) CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27: 4733-4744.
18. del Peso L, González VM, Hernández R, Barr FG, Núñez G, (1999) Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18: 7328-7333.
19. Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, et al. (2006) Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther 5: 1299-1308.
20. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, et al. (2010) Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 70: 6497-6508.
21. Dietz KN, Miller PJ, Iyengar AS, Loupe JM, Hollenbach AD, (2011) Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation. Int J Biochem Cell Biol 43: 936-945.
22. Dietz KN, Miller PJ, Hollenbach AD, (2009) Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation. Biochemistry 48: 11786-11795.
23. Yan X, Chen H, Lu X, Wang F, Xu W, et al. (2011) Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model. Eur J Pharm Sci 43: 251-259.